Product Showcase

The HHS Intramural Research Programs have invented numerous technologies that were licensed to companies for commercial development and now are on the market. Products showcased on this site are utilized every day to detect, treat or prevent disease or assist researchers as they continue to explore ways to develop newer and more effective health care products and procedures.

The Showcase includes products that are now or have been on the market. Some are FDA-approved and many do not necessitate FDA approval. While there may be multiple inventors on any product, all of whom may not be from HHS, the primary purpose of this Showcase is to highlight the contributions of HHS. 

We hope you will find this Showcase illuminating about the role the HHS Intramural Research Programs have played in the effort to advance significantly our capacity to protect and improve health.

L-078-1996

Human (hu-8845) antibody

Upstate Biotechnology, Incorporated

Identify PLK enzymes in vitro
L-190-1999

Human Cytochrome P450 antibodies

Becton, Dickinson and Company

Selectively and potently inhibits the human cytochrome p450
L-034-1998

Human IL-8

PeproTech, Inc.

Circulating human IL-8 might be a useful, clinically relevant circulating tumor protein marker due to its positive correlation with multiple physiologic variables associated with lung cancer progression
L-004-1997

Human Immunodeficiency Virus (HIV), p24

Dako Denmark A/S

Reacts with and labels cells expressing p24
L-320-1991

Human interleukin 1 beta (IL – 1β) antibody

Upstate Biotechnology, Incorporated

Identify and trace specific cells or molecules in an organism
L-035-1994

Human NM23 Protein & Antibodies

Oncogene Sciences, Inc.

Used to detect NM23 in human tumors to predict the malignancy potential of such tumors
L-146-1994

Human NM23 Proteins & Antibodies

BD Biosciences - BD PharMingen

Expression of the protein correlates with metastatic potential of tumors
L-338-2002

Human p53 PTM antibodies

Trevigen, Inc.

Research tool for studying human p53 protein functions
L-201-1997

Human Thymidylate Synthase Antibody

Oncotech Incorporated

Specifically reacts to human thymidylate synthase
L-004-2003

Human Thymidylate Synthase Antibody

QED Bioscience, Inc.

Used for de novo synthesis of DNA and reacts specifically with human Thymidylate Synthase
L-043-1989

Hybridoma clone 2G9C3 kit

Bayer Corporation

In vivo or in vitro use for detecting or treating human cancer
L-414-1992

Hybridoma MAb13

Becton, Dickinson and Company

Applications in research, diagnostics, and treatment due to its effects on cell attachment, spreading, and migration
L-415-1992

Hybridoma MAb16

Becton, Dickinson and Company

Applications in research, diagnostics, and treatment due to its effects on cell attachment, spreading, and migration
L-123-1996

IL-8 Protein Kit

Research and Diagnostic Systems, Inc.

Detection of individual cells secreting specific cytokines
L-038-1993

Inbred miniature swine SLA haplotypes

Charles River Laboratories

Provides a method of inducing tolerance in a recipient mammal of a first species to a graft from a donor mammal of a second species
L-075-1997

INNO-LIA™ HTLV I/II Score

Innogenetics, N.V.

Diagnostic test that can differentiate between HIV-1 and HIV-2
L-033-2002

Interleukin-2 Antibody

Santa Cruz Biotechnology, Inc.

Used for the detection of IL-2 of human origin
L-117-1997

Interleukin-2 Receptor Antibody

Ancell Corporation

Antibodies against CD25 for potential use as an immunodirected therapy to selectively attack (kill) CD25 expressing cells
L-136-1997

Interleukin-8 Protein and Antibodies

BD Biosciences - BD PharMingen

Antibody reacts with the 72 and 77 amino acid forms of human IL-8
L-099-2005

iTAG MHC Mart 1 Tetramer Technology

Beckman Coulter, Inc.

iTAg reagents allow for measurement against one specific peptide
L-262-2001

iTag™ MHC Tetramers

Beckman Coulter, Inc.

Used for the ex vivo quantification of cellular immune response
L-205-2001

K1 antibodies

Zymed Laboratories, Inc.

Used as a research reagent to enhance the understanding of certain cancers, such as, ovarian, esophageal and cervical carcinomas
L-049-1991

Kepivance®

Amgen, Inc.

Treatment of severe mouth sores that afflict hematologic cancer patients who receive myelotoxic therapy
L-266-2000

Keratinocyte Growth Factor & KGF Antibodies

PeproTech, Inc.

Identifies keratinocyte of growth factors, i.e. embryonic development, cell growth, morphogenesis, tumor growth,and invasion
L-163-1997

LambdaSelect-cII™ Mutation Assay Kit

Stratagene California

Detect in vivo mutations of E. coli phage lambda 1
L-183-1997

Long Terminal Repeat Vector

Stratagene California

Uses LTR vectors to screen for a protein of interest.
L-041-1997

LTR-Vectors

Novartis Pharma, Genetic Therapy, Inc.

Used to make retroviral vectors for development of gene therapy products
L-006-1985

LYMErix™

GlaxoSmithKline

A noninfectious recombinant vaccine for Lyme's disease
L-088-1997

Macrophage Stimulating Protein

Research and Diagnostic Systems, Inc.

Activates macrophages to react in the immune system
L-002-2004

MART-1 Antibody

Cell Marque Corporation

Diagnostic assay for metastatic melanoma